Cargando…

Long-term survival following multidisciplinary treatment of metastatic sarcomatoid renal cell carcinoma: a case report

INTRODUCTION: We report the case of a 62-year-old woman diagnosed with sarcomatoid renal cell carcinoma. CASE PRESENTATION: A 62-year-old Asian woman presented with macroscopic hematuria. A histological and immunohistochemical study of a tumor biopsy specimen led to a suspected diagnosis of sarcomat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yaegashi, Hiroshi, Izumi, Kouji, Konaka, Hiroyuki, Mizokami, Atsushi, Namiki, Mikio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652441/ https://www.ncbi.nlm.nih.gov/pubmed/26582158 http://dx.doi.org/10.1186/s13256-015-0751-0

Ejemplares similares

Severe Renal Hemorrhage in a Pregnant Woman Complicated with Antiphospholipid Syndrome: A Case Report
por: Kawaguchi, Shohei, et al.
Publicado: (2011)

Decreasing trend in prostate cancer with high serum prostate-specific antigen levels detected at first prostate-specific antigen-based population screening in Japan
por: Kitagawa, Yasuhide, et al.
Publicado: (2014)

Understanding prostate-specific antigen dynamics in monitoring metastatic castration-resistant prostate cancer: implications for clinical practice
por: Mizokami, Atsushi, et al.
Publicado: (2017)

An Unusual Prostate-Specific Antigen Decrease in an Advanced Castration-Resistant Prostate Cancer Patient with Intracerebral Hemorrhage Subsequently Treated with Luteinizing Hormone-Releasing Hormone Antagonist
por: Izumi, Kouji, et al.
Publicado: (2013)

Long response duration to pembrolizumab in metastatic, castration-resistant prostate cancer with microsatellite instability-high and neuroendocrine differentiation: A case report
por: Yoshida, Tsukasa, et al.
Publicado: (2022)

Prospective longitudinal comparative study of health-related quality of life and treatment satisfaction in patients treated with hormone therapy, radical retropubic prostatectomy, and high or low dose rate brachytherapy for prostate cancer
por: Miwa, Sotaro, et al.
Publicado: (2013)

Testosterone Deficiency and Nocturia: A Review
por: Shigehara, Kazuyoshi, et al.
Publicado: (2017)

Development of a Prognostic Model of Overall Survival for Metastatic Hormone-Naïve Prostate Cancer in Japanese Men
por: Nakagawa, Ryunosuke, et al.
Publicado: (2022)

A case of adrenal lymphangioma resected laparoscopically with minimal invasiveness
por: Yaegashi, Hiroshi, et al.
Publicado: (2020)

Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation
por: Izumi, Kouji, et al.
Publicado: (2013)

First-line immune checkpoint inhibitors for patients with metastatic urothelial carcinoma treated in routine clinical practice
por: Naito, Renato, et al.
Publicado: (2020)

Sarcomatoid carcinoma of the pancreas with rare long-term survival: a case report
por: Kimura, Toshihisa, et al.
Publicado: (2020)

Efficacy and Safety of First-Line Cytokines versus Sunitinib and Second-Line Axitinib for Patients with Metastatic Renal Cell Carcinoma (ESCAPE Study): A Phase III, Randomized, Sequential Open-Label Study
por: Kadono, Yoshifumi, et al.
Publicado: (2023)

Optimal treatment for castration-resistant prostate cancer
por: Izumi, Kouji, et al.
Publicado: (2014)

Testosterone Replacement Therapy for Patients with Hypogonadism after High Dose-Rate Brachytherapy for High-Risk Prostate Cancer: A Report of Six Cases and Literature Review
por: Kadomoto, Suguru, et al.
Publicado: (2020)

Epidemiology and Prevention of Renal Cell Carcinoma
por: Makino, Tomoyuki, et al.
Publicado: (2022)

Efficacy and safety of cytokines versus first-line sunitinib and second-line axitinib for patients with metastatic renal cell carcinoma (ESCAPE study): A study protocol for phase III randomized sequential open-label study
por: Kadono, Yoshifumi, et al.
Publicado: (2019)

Risk Factors Affecting Decreased Libido Among Middle-Aged to Elderly Men; Nocturnal Voiding is an Independent Risk Factor of Decreased Libido
por: Shigehara, Kazuyoshi, et al.
Publicado: (2021)

Comparison of Clinical Outcomes between Robot-Assisted Partial Nephrectomy and Cryoablation in Elderly Patients with Renal Cancer
por: Kawaguchi, Shohei, et al.
Publicado: (2022)

Ischemic proctitis after low‐dose‐rate brachytherapy using hydrogel spacer for prostate cancer
por: Toriumi, Ren, et al.
Publicado: (2022)

Impact of Pelvic Anatomical Changes Caused by Radical Prostatectomy
por: Kadono, Yoshifumi, et al.
Publicado: (2022)

Trends of clinical symptoms and prognosis of middle-aged prostate cancer patients after instigation of prostate specific antigen-based population screening
por: Kitagawa, Yasuhide, et al.
Publicado: (2013)

Survival Outcomes and Tumor IMP3 Expression in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma
por: Tantravahi, Srinivas K., et al.
Publicado: (2015)

A novel screening strategy for clinically significant prostate cancer in elderly men over 75 years of age
por: Iwamoto, Hiroaki, et al.
Publicado: (2020)

Suppressive Role of Androgen/Androgen Receptor Signaling via Chemokines on Prostate Cancer Cells
por: Izumi, Kouji, et al.
Publicado: (2019)

Combination of Sarcopenia and Hypoalbuminemia Is a Poor Prognostic Factor in Surgically Treated Nonmetastatic Renal Cell Carcinoma
por: Makino, Tomoyuki, et al.
Publicado: (2023)

Expression and regulatory effects on cancer cell behavior of NELL1 and NELL2 in human renal cell carcinoma
por: Nakamura, Ritsuko, et al.
Publicado: (2015)

Efficacy of chemotherapy on overall survival in metastatic sarcomatoid bladder cancer patients
por: Tappero, Stefano, et al.
Publicado: (2022)

Sarcomatoid renal cell carcinoma: MRI features and their association with survival
por: Cheng, Monica, et al.
Publicado: (2023)

Peritoneal sarcomatoid mesothelioma in a sika deer
por: MATSUDA, Kazuya, et al.
Publicado: (2019)

Effects of long-term androgen replacement therapy on the physical and mental statuses of aging males with late-onset hypogonadism: a multicenter, randomized controlled trial in Japan (EARTH Study)
por: Konaka, Hiroyuki, et al.
Publicado: (2016)

Comparison of the Prognostic Value of Inflammatory and Nutritional Indices in Nonmetastatic Renal Cell Carcinoma
por: Makino, Tomoyuki, et al.
Publicado: (2023)

Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Castration-Sensitive Prostate Cancer
por: Iwamoto, Hiroaki, et al.
Publicado: (2022)

Enzalutamide versus abiraterone as a first-line endocrine therapy for castration-resistant prostate cancer (ENABLE study for PCa): a study protocol for a multicenter randomized phase III trial
por: Izumi, Kouji, et al.
Publicado: (2017)

Tumor-Associated Macrophages Induce Migration of Renal Cell Carcinoma Cells via Activation of the CCL20-CCR6 Axis
por: Kadomoto, Suguru, et al.
Publicado: (2019)

The CCL20-CCR6 Axis in Cancer Progression
por: Kadomoto, Suguru, et al.
Publicado: (2020)

Undesirable Status of Prostate Cancer Cells after Intensive Inhibition of AR Signaling: Post-AR Era of CRPC Treatment
por: Makino, Tomoyuki, et al.
Publicado: (2021)

Is the C-C Motif Ligand 2–C-C Chemokine Receptor 2 Axis a Promising Target for Cancer Therapy and Diagnosis?
por: Iwamoto, Hiroaki, et al.
Publicado: (2020)

Roles of CCL2-CCR2 Axis in the Tumor Microenvironment
por: Kadomoto, Suguru, et al.
Publicado: (2021)

Macrophage Polarity and Disease Control
por: Kadomoto, Suguru, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3j804mh9srregg89v5o2chtf68